Image For Activity Cover
Long-acting Buprenorphine Treatment for Opioid Use Disorder
Lack of knowledge about available long-acting buprenorphine formulations has led their under-utilization in the health care system, despite large unmet treatment needs among those with opioid use disorder. A multi-disciplinary approach that includes the collaboration between nurse practitioners, PAs, physicians, psychologists, social workers and hospital administrators is necessary to address this gap in knowledge and provide evidence-based care to those with opioid use disorder. Several newly approved long-acting buprenorphine formulations give patients and providers new options to consider. This webinar will review the peer-reviewed publications from three FDA-approved long-acting products, their FDA-approved indications, practical information on how to use them in clinical practice, ongoing NIDA clinical trials employing these long-acting medications, and patient case scenarios.
Target Audience
Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, pharmacists, social workers, and healthcare teams.
Michelle Lofwall, MD, DFASAM, University of Kentucky Medicine
Credit Designations Available
AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, CEUs, SW CE credit, Interprofessional Continuing Education (IPCE) credit, and Pharmacy Continuing Education Credit.
Core Competencies as a result of participating in this activity
Interpersonal Skills and Communication
Medical Knowledge
Systems-based practice
Educational Objectives
To identify the FDA indications for long-acting buprenorphine implants and subcutaneous injections, to explain the storage requirements for long-acting buprenorphine formulations, and to compare the potential advantages and disadvantages of these new formulations in patient care.
Method of participating in the learning process
In order to receive maximum credit, learners must:

1. Review the materials provided in this module.
2. Earn a score of 100% on the post-test.
3. Complete knowledge-based assessment questions to assess both prior knowledge and knowledge change following the activity
4. Complete an evaluation to assess satisfaction and plans for individual and/or team practice change.
5. Follow instructions at the end of the course regarding how to retrieve a certificate.*

*Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible (in part) by grant nos. 6H79TI081968 and 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For Buprenorphine Training Inquiries, email PCSS.


Powered By